Adipoparacrinology - Vascular periadventitial adipose tissue (Tunica adiposa) as an example

Cell Biology International

Volumn 36, Issue 3, 2012, Pages 327-330

  Chaldakov, George N ^a   Beltowsky, Jerzy ^b   Ghenev, Peter I ^a   Fiore, Marco ^c   Panayotov, Plamen ^d   Rančič, Gorana ^c,e   Aloe, Luigi ^c  

^a MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c CNR   (Italy)

^d UNIVERSITY HOSPITAL ST MARINA   (Bulgaria)

^e UNIVERSITY OF NI   (Serbia)

Author keywords

Adipobiology; Adipokines; Adipose tissue; Cardiometabolic disease; Vascular wall

Indexed keywords

ADIPOSE TISSUE; ADVENTITIA; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL; BLOOD VESSEL WALL; CARDIOMETABOLIC DISEASE; HEART; HEART DISEASE; HUMAN; HYPERTENSION; INTIMA; LYMPH NODE; METABOLIC DISORDER; OVARY; PANCREAS; PATHOGENESIS; PROSTATE; TUNICA MEDIA; VASCULAR PERIADVENTITIAL ADIPOSE TISSUE;

ADIPOSE TISSUE; CONNECTIVE TISSUE; HUMANS; TUNICA INTIMA; TUNICA MEDIA;

ALOE;

EID: 84859253764     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20110422     Document Type: Article

References (43)

1. Aghamohammadzabeh R, Withers SB, Lynch FM, Greenstein AS, Malik R, Heagerty AM. Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target. Br J Pharmacol 2011;doi:10.1111/j. 1476-5381.2011.01479.x.
2. Bays HE. Adiposopathy is 'sick fat' a cardiovascular disease? J Am Coll Cardiol 2011;57:2461-73.
3. Britton KA, Fox CS. Perivascular adipose tissue and vascular disease. Clin Lipidol 2011;6:79-91.
4. Chaldakov GN, Vankov VN. Morphological aspects of secretion in the arterial smooth muscle cell, with special reference to the Golgi complex and microtubular cytoskeleton. Atherosclerosis 1986;61:175-92
5. Chaldakov GN, Fiore M, Ghenev PI, Stankulov IS, Aloe L. Atherosclerotic lesions: possible interactive involvement of intima, adventitia and associated adipose tissue. Int Med J 2000;7:43-9.
6. Chaldakov GN, Stankulov IS, Aloe L. Subepicardial adipose tissue in human coronary atherosclerosis: another neglected phenomenon. Atherosclerosis 2001a;154:237-8.
7. Chaldakov GN, Stankulov IS, Fiore M, Ghenev PI, Aloe L. Nerve growth factor levels and mast cell distribution in human coronary atherosclerosis. Atherosclerosis 2001b;159:57-66.
8. Chaldakov GN, Stankulov IS, Fiore M, Hristova MG, Rančić G, Ghenev PI et al. Adipoendocrinology and adipoparacrinology: emerging fields of study on the adipose tissue. Biomed Rev 2001c;12:31-9.
9. Chaldakov GN, Stankulov IS, Hristova M, Ghenev PI. Adipobiology of disease: adipokines and adipokine-targeted pharmacology. Curr Pharm Des 2003;9:1023-31.
10. Chaldakov GN, Ghenev PI, Hristova MG, Panayotov P, Aloe L. Perivascular adipose tissue: a novel component of global cardiometabolic risk. CMR eJournal 2010a;3:19-22.
11. Chaldakov GN, Fiore M, Rancic G, Ghenev PI, Tuncel N, Beltowski J et al. Rethinking vascular wall: periadventitial adipose tissue (tunica adiposa). Obesity Metab 2010b;6:46-9.
12. Dashwood MR, Dooley A, Shi-Wen X, Abraham DJ, Dreifaldt M, Souza DS. Perivascular fat-derived leptin: a potential role in improved vein graft performance in coronary artery bypass surgery. Interact Cardiovasc Thorac Surg 2011;12:170-3.
13. de Feyter PJ. Epicardial adipose tissue: an emerging role for the development of coronary atherosclerosis. Clin Cardiol 2011;34:143-4.
14. Frost R. The road not taken. In: Mountain interval. New York, NY: Henry Holt and Company; 1916:'...two roads diverged in a wood, and I - I took the one less traveled by, And that has made all the difference.'
15. Gollasch M, Dubrovska G. Paracrine role for periadventitial adipose tissue in the regulation of arterial tone. Trends Pharmacol Sci 2004;25:647-53.
16. Gualillo O, Gonzáez-Juanatey JR, Lago F. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. Trends Cardiovasc Med 2007;17:275-83.
17. Hirata Y, Tabata M, Kurobe H, Motoki T, Akaike M, Nishio C et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol 2011;58:248-55.
18. Louise TE, Saeed N, Hajnal JV, Brynes A, Goldstone AP, Frost G, Bell JD. Magnetic resonance imaging of total body fat. J Appl Physiol 1998;85:1778-85.
19. Lu C, Su LY, Lee RM, Gao YJ. Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: the role of adipocyte-derived angiotensin II. Eur J Pharmacol 2010;634:107-12.
20. Lu C, Su LY, Lee RM, Gao YJ. Alterations in perivascular adipose tissue structure and function in hypertension. Eur J Pharmacol 2011;656:68-73.
21. Matsuzawa Y, Funahashi T, Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb 2011;18:629-39.
22. Meijer RI, Serne EH, Smulders YM, van Hinsbergh VW, Yudkin JS, Eringa EC. Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease. Curr Diab Rep 2011;11:211-7.
23. Ouwens DM, Sell H, Greulich S, Eckel J. The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J Cell Mol Med 2010;14:2223-34.
24. Payne GA, Kohr MC, Tune JD. Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease. Br J Pharmacol 2012;165:659-69.
25. Rančič G, Petrovič A, Sekulovič-Stefanovič L, Bojanič V, Ghenev PI. Adipotopography: TOFI versus TOTI, or a hidden Homo obesus. In: The First International Symposium on Adipobiology and Adipopharmacology, 20 October 2007, Varna, Bulgaria. pp 13-14A.
26. Renes J, Rosenow A, Mariman E. Novel adipocyte features discovered by adipoproteomics. Adipobiology 2009;1:7-18.
27. Ross R. Mechanisms of disease: atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
28. Sacks HS, Fain JN, Cheema P, Bahouth SW, Garrett E, Wolf RY et al. Depot-specific overexpression of proinflammatory, redox, endothelial cell, and angiogenic genes in epicardial fat adjacent to severe stable coronary atherosclerosis. Metab Syndr Relat Disord 2011;9:433-9.
29. Schlett CL, Massaro JM, Lehman SJ, Bamberg F, O'Donnell CJ, Fox CS et al. Novel measurements of periaortic adipose tissue in comparison to anthropometric measures of obesity, and abdominal adipose tissue. Int J Obes (Lond) 2009;33:226-32.
30. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimat formation in injured porcine coronary arteries. Circulation 1996;94:1655-64.
31. Skilton MR, Sérusclat A, Sethu AH, Brun S, Bernard S, Balkau B et al. Noninvasive measurement of carotid extra-media thickness: associations with cardiovascular risk factors and intima-media thickness. JACC Cardiovasc Imaging 2009;2:176-82.
32. Spiroglou SG, Kostopoulos CG, Varakis JN, Papadaki HH. Adipokines in periaortic and epicardial adipose tissue: Differential expression and relation to atherosclerosis. J Atheroscler Thromb 2010;17:115-30.
33. Takaoka M, Nagata D, Kihara S, Shimomura I, Kimura Y, Tabata Y et al. Periadventitial adipose tissue plays a critical role in vascular remodeling. Circ Res 2009;105:906-11.
34. Thomas EL, Parkinson JR, Frost GS, Goldstone AP, Doré CJ, McCarthy JP et al. The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity (Silver Spring) 2012;20:76-87.
35. Töre F, Tonchev AB, Fiore M, Tuncel N, Atanassova P, Aloe L et al. From adipose tissue protein secretion to adipopharmacology of disease. Immunol Endocr Metab Agents Med Chem 2007;7:149-55.
36. Trayhurn P, de Heredia FP, Wang B, de Oliveira C, Gonzalez-Muniesa P, Wood IS. Cellular hypoxia: a key modulator of adipocyte function in obesity? Adipobiology 2009;1:19-26.
37. Van der Loo B, Martin JF. The adventitia, endothelium and atherosclerosis. Int J Microcirc Clin Exp 1997;17:280-8.
38. Vergahen SN, Visseren FLJ. Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis 2011;214:3-10.
39. Wilcox JN, Scott NA. Potential role of the adventitia in arteritis and atherosclerosis. Int J Cardiol 1996;54(Suppl.):S21-35.
40. 2S formation in perivascular adipose tissue. Pharmacol Res 2011;63:68-76.
41. Yang Z, Montani JP. Emerging roles of perivascular adipose tissue in regulation of vascular functions. Immun Endocr Metab Agents Med Chem 2007;7:137-41.
42. Yudkin JS, Eringa E, Stehouwer CD. 'Vasocrine' signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005;365:1817-20.
43. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32.